CLINICAL_TRIALS
trial_result
· 2024-10-15
Clinical Trial Update: Impact of Carrier Solutions for House Dust Mite Allergen on Allergic Reactions [NA]
Summary
A completed clinical trial evaluated carrier solutions for house dust mite allergen and their effect on allergic reactions in allergic rhinitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fraunhofer-Institute of Toxicology and Experimental Medicine | Conditions: Allergic Rhinitis | NA | Status: COMPLETED